![Zhang Xiuping](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhang Xiuping
Direktor/Vorstandsmitglied bei BIOSENSORS INTERNATIONAL GROUP LTD
Aktive Positionen von Zhang Xiuping
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BIOSENSORS INTERNATIONAL GROUP LTD | Direktor/Vorstandsmitglied | 17.10.2014 | - |
Independent Dir/Board Member | 17.10.2014 | - | |
Moelis & Company Asia Ltd.
![]() Moelis & Company Asia Ltd. Investment ManagersFinance Part of Moelis & Co., Moelis & Company Asia Ltd. is a financial advisory services company based in Hong Kong, Hong Kong. The Chinese company was founded by Richard Orders. Zhang Xiuping has been the CEO of the company since 2013. Moelis & Company Asia was acquired by Moelis Asset Management LP on April 30, 2011. | Vorstandsvorsitzender | 27.09.2013 | - |
Karriereverlauf von Zhang Xiuping
Ausbildung von Zhang Xiuping
Rollins College (Florida) | Masters Business Admin |
Statistik
International
Hong Kong | 2 |
Singapur | 2 |
Vereinigte Staaten | 2 |
Operativ
Chief Executive Officer | 1 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sektoral
Finance | 2 |
Health Technology | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Moelis & Company Asia Ltd.
![]() Moelis & Company Asia Ltd. Investment ManagersFinance Part of Moelis & Co., Moelis & Company Asia Ltd. is a financial advisory services company based in Hong Kong, Hong Kong. The Chinese company was founded by Richard Orders. Zhang Xiuping has been the CEO of the company since 2013. Moelis & Company Asia was acquired by Moelis Asset Management LP on April 30, 2011. | Finance |
Biosensors International Group Ltd.
![]() Biosensors International Group Ltd. Medical SpecialtiesHealth Technology Biosensors International Group Ltd. develops, manufactures, and markets medical devices for interventional cardiology and critical care procedures. It operates through the following segments: Interventional Cardiology, Critical Care, Cardiac Diagnostic, and Licensing Revenue. The company was founded in 1990 by Yoh Chie Lu and is headquartered in Singapore. | Health Technology |
- Börse
- Insiders
- Zhang Xiuping
- Erfahrung